EUVIMEDEUVIMED entdecken
Crossref

Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity

Zhengxu Ren, Kun Wang, Yong Zhang, Hui Chen, Yiming Zhu, Hua Li, Jizhong Lou, Haopeng Wang, Chenqi Xu

Cell Chemical Biology · 2024

DOI: 10.1016/j.chembiol.2024.04.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Chemical Biology, 2024. Verfasst von Zhengxu Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Multi-Cell Systems, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology; Unive…. Hauptthemen laut MEDLINE: Signal Transduction, Receptors, Antigen, T-Cell, Hydroxycholesterols. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Shanghai Municipal Natural Science Foundation, Chinese Academy of Sciences, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell receptor (TCR) plays a fundamental role in adaptive immunity, and TCR-T cell therapy holds great promise for treating solid tumors and other diseases. However, there is a noticeable absence of chemical tools tuning TCR activity. In our study, we screened natural sterols for their regulatory effects on T cell function and identified 7-alpha-hydroxycholesterol (7a-HC) as a potent inhibitor of TCR signaling. Mechanistically, 7a-HC promoted membrane binding of CD3ε cytoplasmic domain, a crucial signaling component of the TCR-CD3 complex, through alterations in membrane physicochemical properties. Enhanced CD3ε membrane binding impeded the condensation between CD3ε and the key kinase Lck, thereby inhibiting Lck-mediated TCR phosphorylation. Transient treatments of TCR-T cells with 7a-HC resulted in reduced signaling strength, increased memory cell populations, and superior long-term antitumor functions. This study unveils a chemical regulation of TCR signaling, which can be exploited to enhance the long-term efficacy of TCR-T cell therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionReceptors, Antigen, T-CellHydroxycholesterolsHumansAnimalsMiceT-LymphocytesMice, Inbred C57BLPhosphorylation

Stichwörter der Autor:innen

7-alpha-hydroxycholesterolCD3 membrane bindingT cell receptorTCR-T cell therapymembrane physicochemical properties

Substanzen

Receptors, Antigen, T-CellHydroxycholesterols

Autor:innen und Institutionen

  • Key Laboratory of Multi-Cell Systems, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology; University of Chinese Academy of Sciences, Chinese Academy of Sciences, Sha…
  • School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Key Laboratory of Epigenetic Regulation and Intervention, Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
  • Key Laboratory of Epigenetic Regulation and Intervention, Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China. Electronic address: jlou@ibp.ac.cn.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China. Electronic address: wanghp@shanghaitech.edu.cn.

Förderung

  • Shanghai Municipal Natural Science Foundation
  • Chinese Academy of Sciences
  • Ministry of Science and Technology of the People's Republic of China
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
  • Program of Shanghai Academic Research Leader

Zitieren

APA

Ren, Z., Wang, K., Zhang, Y., Chen, H., Zhu, Y., Li, H., Lou, J., Wang, H., & Xu, C. (2024). Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity. Cell Chemical Biology. https://doi.org/10.1016/j.chembiol.2024.04.005

Vancouver

Ren Z, Wang K, Zhang Y, Chen H, Zhu Y, Li H, et al. Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity. Cell Chemical Biology. 2024. doi:10.1016/j.chembiol.2024.04.005

BibTeX
@article{Ren2024,
  author = {Ren, Zhengxu and Wang, Kun and Zhang, Yong and Chen, Hui and Zhu, Yiming and Li, Hua and Lou, Jizhong and Wang, Haopeng and Xu, Chenqi},
  title = {Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity},
  journal = {Cell Chemical Biology},
  year = {2024},
  doi = {10.1016/j.chembiol.2024.04.005}
}
Kostenlos starten →